CHILDREN born moderate to late preterm (MLP, 32–36 weeks’ gestation) exhibit poorer cognitive and academic performance, and ...

These findings demonstrate that the oral microbiome is intricately linked to mental health in pregnant women, differing from ...

RESEARCH presented at the 2024 Annual Meeting of the American Foregut Society suggests that gastroparesis diagnoses based ...

Dosciver a study that has shown that conditions such as cerebral infarction, acute myocardial infarction, and venous ...

Discover how recaticimab delivers significant LDL-C reduction with extended 12-week dosing, enhancing lipid-lowering therapy ...

Discover how machine learning predicts sepsis-associated ARDS and mortality with high accuracy. Learn about the potential for ...

A new scoring system identifies risk factors for disease recurrence after stem cell transplantation in leukemia patients, ...

In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales. Read more.

Discover a study that shows that modulating STAT6 directly may represent an innovative strategy for managing severe, ...

Phase 3 psoriasis trial results highlight the efficacy and safety of icotrokinra, an oral IL-23 therapy showing promise for ...

New research reveals rare aneuploid cells in healthy breast tissues, showing cancer-like mutations that increase with age, ...

Pfizer's anti-tissue factor pathway inhibitor has been approved for the treatment of haemophilia A & B by the European Commission.